Patents by Inventor Phillippe Laflamme

Phillippe Laflamme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8153369
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing colorectal cancer comprising detecting a single nucleotide polymorphism (SNP).
    Type: Grant
    Filed: June 5, 2007
    Date of Patent: April 10, 2012
    Assignees: Cancer Care Ontario, McGill University
    Inventors: Michelle Cotterchio, Steven Gallinger, Celia Greenwood, Thomas J. Hudson, Brent W. Zanke, Michael Phillips, Saravanan Sundararajan, Alexandre Montpetit, Phillippe Laflamme, Vincent Ferretti
  • Publication number: 20110189663
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing colorectal cancer comprising detecting a single nucleotide polymorphism (SNP).
    Type: Application
    Filed: March 5, 2008
    Publication date: August 4, 2011
    Applicants: CANCER CARE ONTARIO, MCGILL UNIVERSITY
    Inventors: Michelle Cotterchio, Steven Gallinger, Celia Greenwood, Thomas J. Hudson, Brent W. Zanke, Michael Phillips, Saravanan Sundararajan, Alexandre Montpetit, Phillippe Laflamme, Vincent Ferretti
  • Publication number: 20100047782
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing colorectal cancer comprising detecting a single nucleotide polymorphism (SNP).
    Type: Application
    Filed: June 5, 2007
    Publication date: February 25, 2010
    Applicants: CANCER CARE ONTARIO, MCGILL UNIVERSITY
    Inventors: Michelle Cotterchio, Steven Gallinger, Celia Greenwood, Thomas J. Hudson, Brent W. Zanke, Michael Phillips, Saravanan Sundararajan, Alexandre Montpetit, Phillippe Laflamme, Vincent Ferretti